ArticleBMJ open2021

Phase II multicentre, double-blind, randomised trial of ustekinumab in adolescents with new-onset type 1 diabetes (USTEK1D): trial protocol.

John W Gregory et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.